AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30583926 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery for distraction osteogenesis in M2A type mandible
Number of subjects: 40
Study 30583926 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery for distraction osteogenesis in M2B type mandible
Number of subjects: 40
Study 30583926 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery for distraction osteogenesis in M3 type mandible
Number of subjects: 40
Study 28570481 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial interventions (specifics not provided)
Number of subjects: 290
Study 25992488 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone (50 mg/day)
Number of subjects: 20
Study 25992488 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide (1 mg/day)
Number of subjects: 20
Study 25992488 — intervention group
Group type: COMPARATOR
Intervention: Eplerenone and Indapamide
Number of subjects: 20
Study 23084000 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with DCAD of -300 mEq/kg DM
Number of subjects: 6
Study 23084000 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with DCAD of 50 mEq/kg DM + 25(OH)D (3 mg/steer per day)
Number of subjects: 6
Study 23084000 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with DCAD of 150 mEq/kg DM + 25(OH)D (3 mg/steer per day)
Number of subjects: 6
Study 23084000 — intervention group
Group type: COMPARATOR
Intervention: Diets with DCADs of 50 to 250 mEq/kg DM without 25(OH)D
Number of subjects: 6
Study 21788266 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy based on the Bobath concept, including one hour of structured task practice.
Number of subjects: 26
Study 21788266 — intervention group
Group type: COMPARATOR
Intervention: Structured task practice alone.
Number of subjects: 26
Study 21788266 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Bobath and task practice)
Number of subjects: 26
Study 19288251 — intervention group
Group type: EXPERIMENTAL
Intervention: SM(mod) - modified stapled mucosectomy (ligation and cutting of residual haemorrhoids)
Number of subjects: 45
Study 19288251 — intervention group
Group type: COMPARATOR
Intervention: SM(std) - standard stapled mucosectomy
Number of subjects: 45
Study 19288251 — intervention group
Group type: EXPERIMENTAL
Intervention: SM(mod) - modified stapled mucosectomy
Number of subjects: 45
Study 16960515 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 30
Study 16960515 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 15515745 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid hormone (thyroxine) replacement
Number of subjects: 24
Study 15515745 — intervention group
Group type: COMPARATOR
Intervention: Hypothyroidic condition
Number of subjects: 24
Study 15515745 — intervention group
Group type: COMPARATOR
Intervention: Unchanged group (no thyroxine treatment)
Number of subjects: 24
Study 15515745 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 24
Study 11318050 — intervention group
Group type: EXPERIMENTAL
Intervention: Impeded parafoveal processing
Number of subjects: 0
Study 11318050 — intervention group
Group type: COMPARATOR
Intervention: Normal parafoveal processing
Number of subjects: 0
Study 11318050 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct monitoring of eye movements
Number of subjects: 0
Study 9241335 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS3,3
Number of subjects: 45
Study 9241335 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS3,2
Number of subjects: 45
Study 9241335 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified DBS
Number of subjects: 45
Study 7948054 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive medication
Number of subjects: 1628
Study 7948054 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic drug use
Number of subjects: 1628
Study 2904827 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study 2904827 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 0
Study 2904827 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 0
Study 2904827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31926085 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment in children
Number of subjects: 1348
Study 31926085 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin prescription in children
Number of subjects: 1348
Study 31926085 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin prescription in adults
Number of subjects: 1348
Study 31926085 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin prescription in adults
Number of subjects: 1348
Study 31926085 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin prescription in children
Number of subjects: 1348
Study 29635499 — intervention group
Group type: EXPERIMENTAL
Intervention: AA‐ORS
Number of subjects: 40
Study 29635499 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐ORS
Number of subjects: 40
Study 29635499 — intervention group
Group type: EXPERIMENTAL
Intervention: SpD
Number of subjects: 40
Study 29635499 — intervention group
Group type: COMPARATOR
Intervention: water
Number of subjects: 40
Study 28192629 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (960 mg twice daily)
Number of subjects: 170
Study 28192629 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 170
Study 26319384 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric balloon intervention for 6 months
Number of subjects: 18
Study 26319384 — intervention group
Group type: COMPARATOR
Intervention: Control group (18 healthy volunteers)
Number of subjects: 18
Study 23514100 — intervention group
Group type: EXPERIMENTAL
Intervention: Families for Health V2
Number of subjects: 120
Study 23514100 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study 21558586 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing red
Number of subjects: 0
Study 21558586 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing an opponent in red
Number of subjects: 0
Study 19290549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 7
Study 19290549 — intervention group
Group type: COMPARATOR
Intervention: Proton Pump Inhibitors
Number of subjects: 7
Study 16702367 — intervention group
Group type: EXPERIMENTAL
Intervention: Current cigarette use
Number of subjects: 4383
Study 16702367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes smoked per day, smoking duration, and pack‐years
Number of subjects: 4383
Study 15232813 — intervention group
Group type: COMPARATOR
Intervention: Intercostal nerve block plus IV PCA morphine (G1)
Number of subjects: 31
Study 15232813 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine and fentanyl PCA infusion (G2)
Number of subjects: 31
Study 11422533 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide-laurocapram (TNX)
Number of subjects: 150
Study 11422533 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide (TN)
Number of subjects: 150
Study 11422533 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control formulation (AN)
Number of subjects: 150
Study 8996133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg twice daily) with dexamethasone (8 mg twice on days 2 and 3, and 4 mg twice on day 4)
Number of subjects: 322
Study 8996133 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (20 mg every 6 hours) with dexamethasone (8 mg twice on days 2 and 3, and 4 mg twice on day 4)
Number of subjects: 322
Study 8996133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg twice daily) with dexamethasone
Number of subjects: 322
Study 8996133 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (20 mg every 6 hours) with dexamethasone
Number of subjects: 322
Study 8996133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg twice daily) in patients who vomited in the first 24 hours
Number of subjects: 322
Study 8996133 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (20 mg every 6 hours) in patients who vomited in the first 24 hours
Number of subjects: 322
Study 8488369 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 60
Study 8488369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 2906696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarenal infusion of an alpha 1‐antagonist
Number of subjects: 0
Study 2906696 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockade of alpha 2‐receptors
Number of subjects: 0
Study 2906696 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha 2‐receptors
Number of subjects: 0
Study 29135728 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal distraction device
Number of subjects: 64
Study 29135728 — intervention group
Group type: COMPARATOR
Intervention: External distraction device
Number of subjects: 64
Study 27522871 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair analysis for Cannabis
Number of subjects: 1285
Study 27522871 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair analysis for Street Opioids
Number of subjects: 1285
Study 27522871 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair analysis for Cocaine
Number of subjects: 1285
Study 27522871 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair analysis for Prescribed Opioids
Number of subjects: 1285
Study 27522871 — intervention group
Group type: COMPARATOR
Intervention: Self-reported drug use (TLFB)
Number of subjects: 1285
Study 24399455 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic field therapy (2 Hz) applied to each hip region for 20 min, n = 35
Number of subjects: 66
Study 24399455 — intervention group
Group type: COMPARATOR
Intervention: Placebo magnetic field therapy applied to each hip region for 20 min, n = 31
Number of subjects: 66
Study 24074502 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 30 mg perioperatively
Number of subjects: 41
Study 24074502 — intervention group
Group type: COMPARATOR
Intervention: No dexamethasone
Number of subjects: 41
Study 20870234 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0
Study 20870234 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise
Number of subjects: 0
Study 20870234 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0
Study 20870234 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 18853973 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab maintenance therapy (40 mg every other week)
Number of subjects: 499
Study 18853973 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab maintenance therapy (40 mg weekly)
Number of subjects: 499
Study 18853973 — intervention group
Group type: COMPARATOR
Intervention: Placebo after induction therapy
Number of subjects: 499
Study 21063671 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 362
Study 21063671 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 362
Study 15994121 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation therapy combined with sertraline (LPSD group)
Number of subjects: 24
Study 15994121 — intervention group
Group type: COMPARATOR
Intervention: Sertraline monotherapy (Control group)
Number of subjects: 24
Study 12448241 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate single-dose regimen
Number of subjects: 140
Study 12448241 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate 5-day regimen
Number of subjects: 140
Study 12448241 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin single-dose regimen
Number of subjects: 140
Study 12448241 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin 5-day regimen
Number of subjects: 140
Study 9609271 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet (< or = 50 mmol sodium/day)
Number of subjects: 361
Study 9609271 — intervention group
Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 361
Study 7611580 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 36
Study 7611580 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital
Number of subjects: 36
Study 7611580 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 36
Study 7611580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium (0.15 mg/kg and 0.1 mg/kg)
Number of subjects: 36
Study 7611580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium infusion
Number of subjects: 36
Study 2794058 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-329 10 mg
Number of subjects: 8
Study 2794058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 14982 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide (active drug)
Number of subjects: 50
Study 14982 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle control)
Number of subjects: 50
Study 11680667 — intervention group
Group type: COMPARATOR
Intervention: 5 ng/kg/min Ang II
Number of subjects: 9
Study 11680667 — intervention group
Group type: COMPARATOR
Intervention: 0.5 ng/kg/min Ang II
Number of subjects: 9
Study 11680667 — intervention group
Group type: COMPARATOR
Intervention: 1 ng/kg/min Ang II
Number of subjects: 9
Study 29383895 — intervention group
Group type: EXPERIMENTAL
Intervention: Deqi-expectation (DE) group, n=15
Number of subjects: 64
Study 29383895 — intervention group
Group type: COMPARATOR
Intervention: No-deqi-expectation (NDE) group, n=49
Number of subjects: 64
Study 27702747 — intervention group
Group type: EXPERIMENTAL
Intervention: sitting > 14 h/day with hypercaloric energy balance (SH)
Number of subjects: 7
Study 27702747 — intervention group
Group type: EXPERIMENTAL
Intervention: sitting > 14 h/day with net energy balance (SB)
Number of subjects: 7
Study 27702747 — intervention group
Group type: COMPARATOR
Intervention: active walking/standing with net energy balance (WB)
Number of subjects: 7
Study 27702747 — intervention group
Group type: EXPERIMENTAL
Intervention: acute exercise after prolonged sitting (SH and SB)
Number of subjects: 7
Study 24500611 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate vegan diet
Number of subjects: 39
Study 24500611 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate lacto-ovo vegetarian diet
Number of subjects: 39
Study 22669333 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-fat diet (LC/HFD) for 3 days
Number of subjects: 9
Study 22669333 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (ND) for 3 days
Number of subjects: 9
Study 19777316 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximally porous-coated tapered cementless femoral component
Number of subjects: 388
Study 19777316 — intervention group
Group type: COMPARATOR
Intervention: Fully porous-coated cementless femoral component
Number of subjects: 388
Study 18036446 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 1748
Study 18036446 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1748
Study 15734868 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (n = 5)
Number of subjects: 8
Study 15734868 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone (n = 3)
Number of subjects: 8
Study 15734868 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone and Troglitazone
Number of subjects: 8
Study 14522725 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical activity (HPA) treatment with an energy expenditure (EE) goal of 2500 kcal/wk
Number of subjects: 202
Study 14522725 — intervention group
Group type: COMPARATOR
Intervention: Standard behavior therapy (SBT) for obesity with an EE goal of 1000 kcal/wk
Number of subjects: 202
Study 14522725 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical activity (HPA) treatment
Number of subjects: 202
Study 14522725 — intervention group
Group type: COMPARATOR
Intervention: Standard behavior therapy (SBT) for obesity
Number of subjects: 202
Study 10098761 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (PSA screening)
Number of subjects: 20000
Study 10098761 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 20000
Study 8679367 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway removed while anaesthetized
Number of subjects: 60
Study 8679367 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal mask airway removed on awakening
Number of subjects: 60
Study 8679367 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 2068774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 1625
Study 2068774 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1625
Study 6642873 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral stress management training (3 hours individual training)
Number of subjects: 14
Study 6642873 — intervention group
Group type: COMPARATOR
Intervention: Control group (experienced nurses)
Number of subjects: 14
Study 31601587 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent self-management intervention for opioid tapering
Number of subjects: 0
Study 31601587 — intervention group
Group type: EXPERIMENTAL
Intervention: Group attendance
Number of subjects: 0
Study 31601587 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data from interviews and feedback forms
Number of subjects: 0
Study 29792425 — intervention group
Group type: EXPERIMENTAL
Intervention: Roasted barley extract (RBE)
Number of subjects: 15
Study 29792425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29792425 — intervention group
Group type: EXPERIMENTAL
Intervention: Roasted barley extract (RBE) in cold-feeling subjects
Number of subjects: 15
Study 29792425 — intervention group
Group type: COMPARATOR
Intervention: Placebo in cold-feeling subjects
Number of subjects: 15
Study 26942358 — intervention group
Group type: EXPERIMENTAL
Intervention: Quickstart group (etonogestrel implants with mifepristone)
Number of subjects: 476
Study 26942358 — intervention group
Group type: COMPARATOR
Intervention: Afterstart group (etonogestrel implants after abortion)
Number of subjects: 476
Study 26942358 — intervention group
Group type: EXPERIMENTAL
Intervention: Quickstart group
Number of subjects: 476
Study 26942358 — intervention group
Group type: COMPARATOR
Intervention: Afterstart group
Number of subjects: 476
Study 25122041 — intervention group
Group type: EXPERIMENTAL
Intervention: tizanidine 4 mg
Number of subjects: 114
Study 25122041 — intervention group
Group type: COMPARATOR
Intervention: baseline
Number of subjects: 114
Study 25122041 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 114
Study 22997780 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-point group (penetrating acupuncture)
Number of subjects: 60
Study 22997780 — intervention group
Group type: COMPARATOR
Intervention: Western medication group (Sodium Nitroprusside, Mannite, etc.)
Number of subjects: 60
Study 22997780 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-point group
Number of subjects: 60
Study 22997780 — intervention group
Group type: COMPARATOR
Intervention: Western medication group
Number of subjects: 60
Study 20589591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia group (IHG)
Number of subjects: 11
Study 20589591 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 11
Study 17483139 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly support
Number of subjects: 925
Study 17483139 — intervention group
Group type: COMPARATOR
Intervention: Basic support
Number of subjects: 925
Study 16350718 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF concentrations in patients with benign and malignant thyroid tumors
Number of subjects: 45
Study 16350718 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble VEGF receptor concentrations in patients with benign and malignant thyroid tumors
Number of subjects: 45
Study 16350718 — intervention group
Group type: COMPARATOR
Intervention: Comparison with control group (healthy individuals)
Number of subjects: 45
Study 12101195 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of neoadjuvant hormonal treatment (NHT)
Number of subjects: 393
Study 12101195 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 weeks of neoadjuvant hormonal treatment (NHT)
Number of subjects: 393
Study 12101195 — intervention group
Group type: COMPARATOR
Intervention: Immediate surgery
Number of subjects: 393
Study 12101195 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative NHT (12 and 24 weeks)
Number of subjects: 393
Study 10438352 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir, zidovudine, and lamivudine (triple therapy)
Number of subjects: 320
Study 10438352 — intervention group
Group type: COMPARATOR
Intervention: Indinavir (single therapy)
Number of subjects: 320
Study 10438352 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine and lamivudine (two-drug therapy)
Number of subjects: 320
Study 7783254 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% FC‐23
Number of subjects: 5
Study 7783254 — intervention group
Group type: COMPARATOR
Intervention: 40% nitrous oxide
Number of subjects: 5
Study 7783254 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 5
Study 7783254 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% FC‐23
Number of subjects: 5
Study 7783254 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% FC‐23
Number of subjects: 5
Study 7783254 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% FC‐23 during NMR imaging
Number of subjects: 5
Study 2370328 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate cream applied for 0.5 hours
Number of subjects: 0
Study 2370328 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate cream applied for 1.0 hours
Number of subjects: 0
Study 2370328 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate cream applied for 1.5 hours
Number of subjects: 0
Study 2370328 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate cream applied for 16.0 hours
Number of subjects: 0
Study 2370328 — intervention group
Group type: COMPARATOR
Intervention: 0.05% fluocinonide cream applied for 16 hours
Number of subjects: 0